TABLE 4.
Circulation (nM) |
Intrahepatic (fmol/mg) |
|||||
WT | LKO | KO | WT | LKO | KO | |
7-oxoLCA | 15 ± 11 | 91 ± 152** | 360 ± 529*** | 15 ± 10 | 33 ± 34 | 27 ± 21 |
7-oxoLC-Tau | 22 ± 19 | 875 ± 1210* | 407 ± 392*** | 200 ± 188 | 1458 ± 1705*** | 874 ± 945*** |
7-oxoLC-Gly | 14 ± 14 | 4 ± 6 | 18 ± 16 | 8 ± 8 | 10 ± 9 | 2 ± 1 |
The results are expressed in nM as mean ± SD. Wild-type (WT) (n = 24), liver-specific 11β-HSD1-deficient mice (LKO) (n = 16) and global 11β-HSD1-deficient mice (KO) (n = 8). Data represent mean ± SD. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001.